STOCK TITAN

Rani Therapeutics Holdings, Inc. (RANI) Debt by Year

RANI

Rani Therapeutics Holdings, Inc. carried $0 in long-term debt against $18.6M in cash and equivalents at the end of fiscal year 2025. This represents a decrease of 100.0% from the prior fiscal year. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Rani Therapeutics Holdings, Inc. has filed alongside them.

FY2025 annual
Long-Term Debt $0
Cash & Equivalents $18.6M
YoY -100.0%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

RANI Debt & Cash by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-K
Long-Term Debt$0-100.0%$9.6M-60.7%$24.5M-16.0%$29.1M$0-100.0%$2.4M
Cash & Equivalents$18.6M+394.9%$3.8M-35.8%$5.9M-78.3%$27.0M-77.0%$117.5M+60.8%$73.1M

RANI Debt & Cash by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Long-Term DebtN/AN/A$0-100.0%$0-100.0%$2.2M-87.0%$5.9M-71.6%$9.6M-60.7%$13.5M-51.8%$17.2M-41.2%$20.9M-28.6%$24.5M-16.0%$28.1M+99.4%
Cash & Equivalents$4.9M-52.3%$9.6M-4.6%$18.6M+394.9%$4.1M-3.1%$10.2M+126.3%$10.1M+47.0%$3.8M-35.8%$4.3M-14.0%$4.5M-40.2%$6.9M-63.8%$5.9M-78.3%$5.0M-81.7%

What long-term debt means

Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.

More Rani Therapeutics Holdings, Inc. financials

Frequently Asked Questions

What was Rani Therapeutics Holdings, Inc.'s long-term debt in fiscal year 2025?

Rani Therapeutics Holdings, Inc. carried $0 in long-term debt against $18.6M in cash and equivalents at the end of fiscal year 2025.

How fast is Rani Therapeutics Holdings, Inc.'s long-term debt growing?

Rani Therapeutics Holdings, Inc. (RANI) long-term debt fell by 100.0% year over year, from $9.6M to $0 in fiscal year 2025.

How has Rani Therapeutics Holdings, Inc.'s long-term debt changed over the years?

Across the 6 fiscal years this page covers, Rani Therapeutics Holdings, Inc. (RANI) long-term debt went from $2.4M in fiscal year 2020 to $0 in fiscal year 2025.

Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what Rani Therapeutics Holdings, Inc. (RANI) reported on that line in every period on record.